ims-mrl.bsky.social
Research institute based at the University of Cambridge specialising in diabetes, obesity and related endocrine and metabolic disorders.
👤 Joined on 17 October 2024
Followers
Following
Total Posts
@ims-mrl.bsky.social📣 Incretin-based therapies are changing obesity treatment, but who is able to benefit? Another brilliant and impactful article led by @drmariespreckley.bsky.social ✨ Thank you to Dr Adrian Brown for supporting this work. lnkd.in/ehH8Uw_t @imsepidemiology.bsky.social @ims-mrl.bsky.social
Show PostSomatic mutations in autoimmune lymphocytes may allow them to escape tolerance constraints through a polyclonal cascade of somatic evolution @nature.com @sangerinstitute.bsky.social @ims-mrl.bsky.social @cuh.nhs.uk @imartincorena.bsky.social www.nature.com/articles/s41...
Show PostRead 'Polyclonal selection of immune checkpoint mutations in thyroid autoimmunity’ by @sangerinstitute.bsky.social and collaborators in @nature.com ⤵️ www.nature.com/articles/s41...
Show PostAutoimmune diseases may be driven by DNA changes that build up over time in our immune cells. 🧬 New research has identified previously unseen DNA changes that may contribute to thyroid autoimmunity, where the immune system attacks the thyroid gland. 👇 www.sanger.ac.uk/news_item/hi...
Show PostCome and find us on the second floor of the Cambridge Academy for Science and Technology, this Saturday 21 March from 11am-4pm and get hands-on with cancer research in Cambridge as part of the @cambridgefestival.bsky.social! 🥽 🦠 🧬 Find out more ➡️ zurl.co/GC3pX
Show Post